Portugal – Cleaning services – Prestação de Serviços de Limpeza para os 04 (quatro) Complexos de Piscinas da GesLoures, EM

Portugal – Street-cleaning and sweeping services – AQUISIÇÃO DE SERVIÇOS DE HIGIENE URBANA NA FREGUESIA DE MINA DE ÁGUA, POR LOTES, EM NÚMERO DE TRÊS

Portugal – Refuse transport services – 2026_049CP Aquisição de Serviços de Recolha de Areias e Gradados a partir de Instalações de Saneamento do Grupo Águas de Portugal

Portugal – Cleaning services – Aquisição de serviços de higiene e limpeza

Expected Outcome: Successful proposals will contribute to the Chemicals Strategy for Sustainability and Ecodesign for Sustainable Products Regulation, the Chemical Industry Action Plan, the Clean Industrial Deal as well as the Horizon Europe Mission "Restore our Ocean and Waters by 2030" in particular to Objective 2: "Prevent and eliminate pollution of our oceans, Seas and waters". Projects results are expected to contribute to the following expected outcomes: Full industrial scale biorefinery and related value chain(s) to produce SSbD bio-based solutions for home and/or personal care sector with significantly improved sustainability. Wider availability of bio-based products in home and/or personal care sector meeting both regulatory standards and technical performance requirements. Increased consumer/end user acceptance of bio-based solutions, facilitating market uptake. Contribution to the EU strategic autonomy, resilience and competitiveness, reducing the fossil feedstock dependence for chemicals production and minimising biomass imports dependencies. Scope: The home and personal care sector, including fast-moving consumer goods (FMCG) and cosmetics, is a key industry where…

Expected Outcome: Successful proposals will contribute to the implementation of the Zero Pollution Action Plan, the Circular Economy Action Plan, the Ecodesign for Sustainable Products Regulation, the Chemicals Strategy for Sustainability and the Chemical Industry Action Plan. They will provide solutions in line with the objectives of the EU legislation on waste but also the Horizon Europe Mission "Restore our Ocean and Waters by 2030" in particular to Objective 2: "Prevent and eliminate pollution of our oceans, Seas and waters” as well as the Horizon Europe Mission “A Soil Deal for Europe”, in particular objectives “Reduce soil pollution and enhance restoration”. Projects results are expected to contribute to the following expected outcomes: Wider availability of bio-based additives targeting high functional properties, stability and compatibility with polymers/matrices. Contribution to improved circularity of end products in relevant market sectors. Potential replicability into other industrial sectors to widen market opportunity. Reduction or avoidance of environmental impacts related to life cycle of additives and additive-containing materials and/or products. Scope: While…

Expected Outcome: Project results are expected to contribute to all the following expected outcomes: the effectiveness of the protection of habitats and species in protected areas is maintained even under intensifying impacts of the drivers of biodiversity loss, including climate change, thanks to an improved understanding of how they affect the conservation status of the protected habitats and species, for the benefit of society; managers of protected areas are able to anticipate the future impacts of drivers of biodiversity loss and can take better informed decisions for the protection of terrestrial, freshwater and/or marine habitats and species. Scope: Protected areas are key to ensure the conservation of species and habitats. However, the intensification of the main drivers of biodiversity loss is raising questions on how their effectiveness will be maintained in the future. This topic is expected to support the EU commitment to legally protect a minimum of 30% of the EU’s land area and a minimum of 30% of the EU’s sea area of the EU biodiversity strategy for 2030 (target 1) and the related legislation, and the corresponding target of the Kunming-Montreal Global Biodiversity…

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that employ mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally

Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots. There are two funding opportunities per year that are open to all targets.